Brind.

David Young is a co-founder of Processa Pharmaceuticals, Inc.

1 report, 1 independent Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

David Young is a co-founder of Processa Pharmaceuticals, Inc.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • David Young

    researcher ORCID ID = 0000-0002-8290-5561

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Insider Stock Buyers At Processa Pharmaceuticals Recouped Some Losses This Week Insiders who bought US$213.4k worth of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) stock in the last year recovered pa